Plakous Therapeutics

About:

Plakous Therapeutics is a human biologics company that specializes in restorative and regenerative healing.

Website: https://plakoustherapeutics.com

Top Investors: Altis Biosystems, North Carolina Biotechnology Center, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), One North Carolina Small Business Program

Description:

Plakous Therapeutics, a human biologics company that specializes in restorative and regenerative healing. The company advances in regenerative healing by manufacturing bio-therapeutics from the post-delivery human placenta. It establishes a safe and effective therapeutic platform to promote and sustain healing using the placental cytokines and growth factors that orchestrate fetal development and also allow the body to heal itself. Seth Tomblyn and Scott Washburn co-founded the company in 2016 and Headquartered in Winston Salem, North Carolina.

Total Funding Amount:

$3.66M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Winston Salem, North Carolina, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)plakoustherapeutics.com

Founders:

Scott Washburn, Seth Tomblyn

Number of Employees:

1-10

Last Funding Date:

2022-12-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai